Evidence map›Paper›PMID 28382159›Full record

ArticleTheranostics2017

A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke.

Hsu-Tung Lee, Shih-Ping Liu, Chen-Huan Lin, Sophie Wei Lee, Chung Y Hsu, Huey-Kang Sytwu, Chia-Hung Hsieh, Woei-Cherng Shyu

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. CXCL14 Chemokine Exacerbates Acute Viral Hepatitis in Coronavirus MHV-Infected Mice and Is Associated With Human Acute Viral Hepatitis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Brain regulatory T cells.Nature reviews. Immunology · 2024
    Review
  14. Article
  15. Article
  16. Tumor-associated CD8Frontiers in immunology · 2024
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hsu-Tung LeeDepartment of Neurosurgery, Taichung Veterans General Hospital, Taichung, Taiwan 40421.
Shih-Ping LiuGraduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, Republic of China.; Translational Medicine Research Center and Department of Neurology, China Medical University & Hospital, Taichung, Taiwan, Republic of China.
Chen-Huan LinTranslational Medicine Research Center and Department of Neurology, China Medical University & Hospital, Taichung, Taiwan, Republic of China.
Sophie Wei LeeTranslational Medicine Research Center and Department of Neurology, China Medical University & Hospital, Taichung, Taiwan, Republic of China.
Chung Y HsuGraduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, Republic of China.
Huey-Kang SytwuDepartment of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Chia-Hung HsiehGraduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, Republic of China.; Department of Biomedical Informatics, Asia University, No. 500, Lioufeng Road, Taichung, Taiwan, Republic of China.
Woei-Cherng ShyuGraduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan, Republic of China.; Translational Medicine Research Center and Department of Neurology, China Medical University & Hospital, Taichung, Taiwan, Republic of China.
China Medical University · TWAsia University · TWNational Defense Medical Center · TWTaichung Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory processes have a detrimental role in the pathophysiology of ischemic stroke. However, little is known about the endogenous anti-inflammatory mechanisms in ischemic brain. Here, we identify CXCL14 as a critical mediator of these mechanisms. CXCL14 levels were upregulated in the ischemic brains of humans and rodents. Moreover, hypoxia inducible factor-1α (HIF-1α) drives hypoxia- or cerebral ischemia (CI)-dependent CXCL14 expression via directly binding to the CXCL14 promoter. Depletion of CXCL14 inhibited the accumulation of immature dendritic cells (iDC) or regulatory T cells (Treg) and increased the infarct volume, whereas the supplementation of CXCL14 had the opposite effects. CXCL14 promoted the adhesion, migration, and homing of circulating CD11c

Indexed as

Lymphocyte ActivationAnimalsChemokines, CXCDendritic CellsHumansRats, Sprague-DawleyStrokeT-Lymphocytes, RegulatoryChemokines, CXCCXCL14 protein, humancerebral ischemiaCXC chemokine 14 (CXCL14)hypoxia inducible factor 1α (HIF-1α).immature dendritic cells (iDC)regulatory T cells (Treg)

Identifiers

PMID28382159
PMCPMC5381249
OpenAlexW2590408006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.